Ludvigsen, M., Kamper, P., Sørensen, B. S., Hamilton Dutoit, S. J., Bendix, K., Møller, M. B.
, Alsner, J., D'Amore, F. A. & Honoré, B. (2013).
Specific degradation pattern of peroxiredoxin-1 correlates with adverse outcome in classical Hodgkin lymphoma patients..
Andersen, MP.
, Kamper, P., Nielsen, P. S., Bendix, K., Riber-Hansen, R., Steiniche, T., Hamilton-Dutoit, S. J., D'Amore, F. A. & Clausen, MR. (2013).
The number of tumour-infiltrating mast cells correlates with adverse prognosis in mixed cellularity, but not nodular sclerosis type, classical Hodgkin lymphoma.
Haematologica.
Madsen, C.
, Pedersen, M. B., Segel, E.
, Bendix, K., Jensen, B. A., Jensen, P., Moelller, M. B., Johansen, P., Munksgaard, L., Brown, P.
& D'Amore, F. A. (2013).
upfront autologous stem-cell transplantation in transformed indolent non-hodgkins lymphoma: An outcome analysis.
Hematological Oncology,
31.
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Pittaluga, S., Jaffe, E. & Wilson, W. H. (2012).
Alemtuzumab (ALZ) in combination with Dose-Adjusted EPOC (DA-EPOCH) has higher efficacy in nodal than in extranodal or leukemic peripheral T-cell lymphoma.
International Journal of Clinical Oncology.
Gang, AO., Pedersen, M.
, D'Amore, F. A., Møller-Pedersen, L., Pedersen, BA., Jensen, P., Pedersen, BB., Møller, MB., Gadeberg, O. V., Ingeberg, S., Mourits-Andersen, T.
, Pulczynski, S., Klausen, TW. & Brown, P. D. N. (2012).
A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO.
Blood,
120(21).
Pedersen, M.
, D'Amore, F. A., Pedersen, L. M., Jensen, B. A.
, Jensen, P., Pedersen, B. B., Møller, M. B., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T.
, Pulczynski, S., Klausen, T. W. & Brown, P. D. N. (2012).
A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, United States.
El-Galaly, T. C., Hutchings, M., Juul Mylam, K., Brown, P. D. N.
, Bukh, A., Kamper, P., Johnsen, H. E. & D'Amore, F. A. (2012).
Clinical Features and Outcome in Newly Diagnosed Hodgkin Lymphoma Patients Presenting with PET/CT-Ascertained Focal Skeletal Lesions.
Vase, M. Ø., Hellberg, Y., larsen, C. S.
, Petersen, E., Schaumburg, H.
, Bendix, K., Ravel, C., Bastien, P.
, Christensen, M. & D'Amore, F. A. (2012).
Development of a splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Acta Haematologica,
128(1), 20-22.
Vase, M. Ø., Hellberg, Y. K.
, Larsen, C. S., Petersen, E., Schaumburg, H.
, Bendix, K., Ravel, C., Bastien, P.
, Christensen, M. & d'Amore, F. (2012).
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Acta Haematologica Polonica,
128(1), 20-2.
https://doi.org/10.1159/000337341
El-Galaly, T. C., Juul Mylam, K., Brown, P. D. N.
, Bukh, A., Johnsen, H. E., Madsen, C.
, D'Amore, F. A. & Hutchings, M. (2012).
Disease Extent in Newly Diagnosed Hodgkin Lymphoma: A Comparison of CT and PET/CT Staged Patients.
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Maryalice, S. S., Pittaluga, S., Jaffe, E. S. & Wilson, W. H. (2012).
Efficacy of alemtuzumab (ALZ) in combination with dose-ajusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma.
Journal of Clinical Oncology,
30(15).
Kamper, P., Bendix, K., Honoré, B., D'Amore, F. A. & Hamilton-Dutoit, S. J. (2012).
Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, GA, United States.
Kamper, P., Bendix, K., Hamilton-Dutoit, S. J., Honoré, B. & D'Amore, F. A. (2012).
Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma: Epstein-Bar Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma.
Blood,
120(21), Article 120.
D'Amore, F. A., Leppä, S., Gomes da Silva, M., Relander, T., Brown, P. D. N., Weidmann, E., Lauritzsen, GF., Pezzutto, A., Van Hoof, A., Van Gelder, M., Doorduijn, J., Wu, KL., Kluin-Nelemans, JC., Lugtenburg, PJ., Jankovska, M., Merup, M., Fagerli, U.-M., Walewski, J., Hagberg, H. ... Toldbod, H. (2012).
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma PatientsTreated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy.
Blood,
120(57).
D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkiaer, E., Vornanen, M. & Toldbod, H. (2012).
High-dose chemotherapy and autologous stem cell transplantation in previously untreated peripheral T-cell lymphoma - final analysis of a large prospective multicenter study (NLG-T-01).
Blood,
118, 331.
Gang, AO., Stroem, C., Pedersen, M.
, D'Amore, F. A., Pedersen, LM.
, Bukh, A., Pedersen, BB., Moeller, MB., Mortensen, L. S., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T.
, Pulczynski, S. & Brown, P. D. N. (2012).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Annals of Oncology,
23(1), 147-153.
https://doi.org/10.1093/annonc/mdr058
El-Galaly, T. C., d'Amore, F., Mylam, K. J., de Nully Brown, P.
, Bøgsted, M., Bukh, A., Specht, L., Loft, A.
, Iyer, V., Hjorthaug, K., Nielsen, A. L., Christiansen, I., Madsen, C., Johnsen, H. E. & Hutchings, M. (2012).
Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography-Staged Treatment-Naive Patients With Hodgkin Lymphoma.
Journal of Clinical Oncology,
30(36), 4508-4514.
https://doi.org/10.1200/JCO.2012.42.4036
D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Ôsterborg, A., Merup, M., Brown, P. D. N., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Gadeberg, OV., Sundström, C., Delabie, J., Ralfkiær, E. M., Vornanen, M. & Toldbod, H. (2012).
Upfront Autologuos Stem Cell Transplantation in Peripheral T-cell Lymphoma (NLG-T-01).
Journal of Clinical Oncology,
30(25), 3093-3099.
Vase, M. Ø., Friis, S., Andrea
, Sørensen, H. T. & D'Amore, F. A. (2011).
Absence of anaplastic large cell lymphoma (ALCL) cases in a very large cohort of Danish women exposed to breast implants: results of a nationwide, population-based study. Blood,
118, 3689.
Pedersen, M. B., Zhao, Y., Arendrup, MC.
, Bendix, K., Bojsen-Møller, M., Mølle, I. & D'Amore, F. A. (2011).
Co-existence of cerebral infection with Rhinocladiella mackenzei and primary central nervous system lymphoma in a HIV-negative patient.
APMIS,
119(3), 221-223.
Vase, M. Ø., Hellberg, YK., Larsen, CS., Schaumburg, H.
, Bendix, K., Ravel, C., Bastien, P.
, Nyvold, C. G., Christensen, M. & D'Amore, F. A. (2011).
Development of splenic marginal zone lymphoma associated with active chronic visceral leishmaniasis. Blood,
118, 5202.
D'Amore, F. A., Gomes da Silva, M., Leppa, S., Relander, T., Pezzutto, A., Lauritzsen, GF., Weidmann, E., Van Gelder, M., Merup, M., Hagberg, H., Fagerli, UM., Brown, P. D. N., Boye Hansen, P., Mariz, JM., Jankovska, M., Walewski, J., Doorduijn, J., van Hoof, A.
, Christiansen, I. ... Toldbod, H. (2011).
First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant. Blood,
118, 4110.
Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L. (2011).
Infliximab Induces Clonal Expansion of γδ-T Cells in Crohn’s Disease: A Predictor of Lymphoma Risk? PLoS One,
6(3), e17890.
https://doi.org/10.1371/journal.pone.0017890
Jantunen, E., Relander, T., Lauritzsen, G., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Østenstad, B., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2011).
Intensive induction chemotherapy followed by autologous stem cell transplantation (ASCT) in patients with enteropathy-associated T-cell lymphoma: a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21), 3565.
Toft-Petersen, M.
, Kamper, P., Albertsen, S., Secher, L., Segel, EK., Clausen, M.
& D'Amore, F. A. (2011).
Monocytosis in the peripheral blood at first relapse/progression predicts poorer overall and progression-free survival after autologous hematopoietic stem cell transplantation in Hodgkin lymphoma. Blood,
118, 1559.
Strandhave, C., Jespersen, B., Jørgensen, KA., Schou, R.
, Søndergaard, E., Bendix, K., Mortensen, LS.
& D'Amore, F. A. (2011).
Posttransplant lymphoproliferative disorders (PTLD) after renal transplantation: Focus on HLA Antigens.
Blood,
116(21), 5074.
Hohloch, K., Lorsbach, M., Windemuth-Kieselbach, C., Gomez-Codina, J., Likesch, W., Jurczak, W., Cacchione, R., Suh, C., Johnsen, AR.
, D'Amore, F. A., Decaudin, D., Zinzani, PL. & Trümper, L. (2011).
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: Registry analysis of 1100 patients by the international Radioimmunotherapy network (RIT-N).
Journal of Nuclear Medicine,
52(9), 1354-1360.
El-Galaly, T. C., D'Amore, F. A., Brown, P. D. N.
, Christiansen, I., Spect, L., Loft, A.
, Bukh, A., Johnsen, HE., Madsen, C. & Hutchings, M. (2011).
Routine bone marrow biopsy adds little diagnostic information in patients with newly diagnosed Hodgkin lymphoma undergoing PET/CT staging. Blood,
118, 2627.
El-Galaly, T. C. E., D'Amore, F. A., Brown, P. D. N.
, Christiansen, I., Specht, L., Loft, A.
, Bukh, A., Johnsen, H. E., Madsen, C. & Hutchings, M. (2011).
Routine Bone Marrow Biopsy Adds Little Diagnostic Information in Patients with Newly Diagnosed Hodgkin Lymphoma Undergoing PET/CT Staging. Poster session presented at ASH, San Diego, United States.
Agostinelli, C., Gallamini, A., Rigacci, L., Vitolo, U., Stracqualursi, L., Piccaluga, P., Stelitano, C., Patti, C., Argani, L., Broccoli, A., Levis, A.
, D'Amore, F. A., Zinzani, P. & Pileri, SA. (2011).
The prognostic value of biologic markers in classical Hodgkin Lymphoma (CHL) patients.
Annals of Oncology,
22(4), 206.
Ludvigsen, M., Kamper, P., Bendix, K., Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B.
, Nyengaard, J. R., D'Amore, F. A. & Honoré, B. (2011).
Translational research identifies prognostic markers including galectin-1 in the tumor microenvironment of cHL predictive for relapsed /refractory disease.
Kamper, P., Bendix, K., Hamilton-Dutoit, S., Honoré, B., Nyengaard, J. R. & d'Amore, F. (2011).
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Haematologica,
96(2), 269-76.
https://doi.org/10.3324/haematol.2010.031542
Relander, T., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2010).
favorable outcome in ALK-negative anaplastic large-cell lymphoma following intensive induction chemotherapy and autologous stem cell transplantation (ASCT): a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21).
Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L. (2010).
Infliximab drives gamma-delta T cell expansion in Crohn's disease - a predictor of lymphoma risk? Blood,
116(21), 4131.
d'Amore, F., Radford, J., Relander, T., Jerkeman, M., Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H. (2010).
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
British Journal of Haematology, Supplement,
150(5), 565-73.
https://doi.org/10.1111/j.1365-2141.2010.08298.x
D'Amore, F. A., Madsen, J., Nielsen, R., Engebjerg, M., Sørensen, H. & Bukh, A. (2010).
Use of statins and prognosis in patients with CD-20-positive "De novo" diffuse large b cell lymphoma (DLBCL) treated with rituximab containing regimens.
Haematologica, 282.
Jepsen, J. R.
, d'Amore, F., Baandrup, U.
, Clausen, M. R., Gottschalck, E. & Aasted, B. (2009).
Aleutian mink disease virus and humans.
Emerging Infectious Diseases (Print Edition),
15(12), 2040-2.
https://doi.org/10.3201/eid1512.090514
D'Amore, F. A., Jurczak, W., Skotnicki, A. B., Deptala, A., Windemuth-Kieselbach, C., Lorsbach, M., Delaloye, A. B., Cheolwon, S., Zinzani, P. L., Cacchione, R., Linkesch, W. & Truemper, L. H. (2009).
Consolidation with radioimmunotherapy may prolong survival in first remission of mantle cell lymphoma patients uneligible for stem cell transplantation, an analysis of the international RIT-network.
Blood,
114(22), 22.
Jørgensen, J. M., Sørensen, F. B., Bendix, K., Nielsen, J. L., Funder, A., Karkkainen, M. J., Tainola, T.
, Sørensen, A. B., Pedersen, F. S. & D'Amore, F. (2009).
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Leukemia & Lymphoma,
50(10), 1647-1660.
https://doi.org/10.1080/10428190903156729,
https://doi.org/10.1080/10428190903156729
Ludvigsen, M., Ostergaard, M.
, Vorum, H., Jacobsen, C. & Honoré, B. (2009).
Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity.
BMC Biochemistry,
10(1), 34.
https://doi.org/10.1186/1471-2091-10-34
Zinzani, P. L.
, d'Amore, F., Bombardieri, E., Brammer, C., Codina, J. G., Illidge, T., Jurczak, W., Linkesch, W., Morschhauser, F., Vandenberghe, E. & Van Hoof, A. (2008).
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop.
European Journal of Cancer,
44(3), 366-73.
https://doi.org/10.1016/j.ejca.2007.12.008